National Diabetes Audit Report 1 Care Processes and Treatment Targets 2016-17

Update: 5 January 2018 - It has been identified that foot surveillance data could have been under-reported for a number of GP practices who use the TPP SystmOne clinical system in 2016-17. Please bear this in mind when reviewing foot surveillance data, particularly at GP practice level. 

Published: 10 November 2017 - The National Diabetes Audit (NDA) is part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP) which is commissioned by the Healthcare Quality Improvement Partnership (HQIP) and funded by NHS England. The NDA is managed by NHS Digital in partnership with Diabetes UK.

The NDA measures the effectiveness of diabetes healthcare against NICE Clinical Guidelines and NICE Quality Standards, in England and Wales. The NDA collects and analyses data for use by a range of stakeholders to drive changes and improvements in the quality of services and health outcomes for people with diabetes.

This short report details the top level findings for the 2016-17 audit. The audit collected data during the Summer of 2017, for the period 1 January 2016 to 31 March 2017. The top level findings, along with supporting data at Clinical Commissioning Group, Local Health Board and GP Practice have been made available to give data back to services in a timely manner that can help drive improvements in the quality of diabetes care locally.

A full report will be published in March 2018, which will contain the full key findings, recommendations, results of analysis for multiple readings, and information for learning disability and severe mental illness.